CB-03

N/A

Report date: 2025/09/17 14:45:05
NME

Base Information

Drug NameCB-03
Drug Alias NameCB-03CB-003CB03-154
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated potassium channel subunit Kv7.2 stimulantsPotassium voltage-gated channel subfamily KQT member 3 stimulants
TargetsVoltage-gated potassium channel subunit Kv7.2Potassium voltage-gated channel subfamily KQT member 3
Therapy Area/IndicationsDepressive DisorderCancer PainNeuralgia +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Zhimeng Biopharma Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Zhimeng Biopharma Inc
Inactive CompaniesN/A
Active IndicationsDepressive DisorderCancer PainNeuralgia +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A